Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX), Nashville, TN – FDA Inspections
Inspection records and compliance data for Cumberland Pharmaceuticals, Inc. in Nashville, Tennessee. 3 FDA inspections on record, last inspected May 18, 2017. Publicly traded as NASDAQ: CPIX.
This profile covers Cumberland Pharmaceuticals, Inc. based in Nashville, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected April 4, 2012. Last inspected May 18, 2017.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 18, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1014011 |
| July 25, 2014 | NAI | Human Drugs · Bioresearch Monitoring | 888639 |
| April 4, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 774914 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Cumberland Pharmaceuticals, Inc.
Stock ticker
CPIX
Exchange
NASDAQ
Share price
$5.04
Market cap
$75.5M
Price as of
November 6, 2026
FEI Number
3003258245
Address
2525 W End Ave Ste 950, Nashville, Tennessee 37203, United States
Country
United States
ID: f56adf34-cf6c-4bd2-ab50-a69b4f5e7142